Moorfields Eye Hospital National Health Service Foundation Trust, London, United Kingdom.
University College London Institute of Ophthalmology, University College London, London, United Kingdom.
Ann Neurol. 2019 Sep;86(3):368-383. doi: 10.1002/ana.25550. Epub 2019 Jul 31.
Autosomal dominant optic atrophy (ADOA) starts in early childhood with loss of visual acuity and color vision deficits. OPA1 mutations are responsible for the majority of cases, but in a portion of patients with a clinical diagnosis of ADOA, the cause remains unknown. This study aimed to identify novel ADOA-associated genes and explore their causality.
Linkage analysis and sequencing were performed in multigeneration families and unrelated patients to identify disease-causing variants. Functional consequences were investigated in silico and confirmed experimentally using the zebrafish model.
We defined a new ADOA locus on 7q33-q35 and identified 3 different missense variants in SSBP1 (NM_001256510.1; c.113G>A [p.(Arg38Gln)], c.320G>A [p.(Arg107Gln)] and c.422G>A [p.(Ser141Asn)]) in affected individuals from 2 families and 2 singletons with ADOA and variable retinal degeneration. The mutated arginine residues are part of a basic patch that is essential for single-strand DNA binding. The loss of a positive charge at these positions is very likely to lower the affinity of SSBP1 for single-strand DNA. Antisense-mediated knockdown of endogenous ssbp1 messenger RNA (mRNA) in zebrafish resulted in compromised differentiation of retinal ganglion cells. A similar effect was achieved when mutated mRNAs were administered. These findings point toward an essential role of ssbp1 in retinal development and the dominant-negative nature of the identified human variants, which is consistent with the segregation pattern observed in 2 multigeneration families studied.
SSBP1 is an essential protein for mitochondrial DNA replication and maintenance. Our data have established pathogenic variants in SSBP1 as a cause of ADOA and variable retinal degeneration. ANN NEUROL 2019;86:368-383.
常染色体显性视神经萎缩(ADOA)在儿童早期开始,表现为视力丧失和色觉缺陷。OPA1 突变是大多数病例的原因,但在一部分具有 ADOA 临床诊断的患者中,病因仍不清楚。本研究旨在鉴定新的 ADOA 相关基因,并探讨其因果关系。
在多代家族和无关患者中进行连锁分析和测序,以鉴定致病变异。使用斑马鱼模型进行计算机预测和实验验证,研究其功能后果。
我们在 7q33-q35 上定义了一个新的 ADOA 基因座,并在 2 个家系和 2 个具有 ADOA 和可变视网膜变性的单体中发现 SSBP1 中的 3 个不同错义变异(NM_001256510.1; c.113G>A [p.(Arg38Gln)], c.320G>A [p.(Arg107Gln)] 和 c.422G>A [p.(Ser141Asn)])。受影响个体中。这些突变的精氨酸残基位于一个碱性补丁的一部分,对于单链 DNA 结合至关重要。这些位置的正电荷丢失很可能降低 SSBP1 与单链 DNA 的亲和力。在斑马鱼中,反义介导的内源性 ssbp1 信使 RNA(mRNA)敲低导致视网膜神经节细胞分化受损。当给予突变的 mRNA 时,会产生类似的效果。这些发现表明 ssbp1 在视网膜发育中具有重要作用,以及鉴定的人类变异具有显性负效应,这与我们研究的 2 个多代家族中观察到的分离模式一致。
SSBP1 是线粒体 DNA 复制和维持所必需的蛋白质。我们的数据已经确定 SSBP1 中的致病变异是 ADOA 和可变视网膜变性的原因。ANN NEUROL 2019;86:368-383.